BR0111202A - Compostos de tienodibenzoazuleno como inibidores do fator de necrose tumoral - Google Patents

Compostos de tienodibenzoazuleno como inibidores do fator de necrose tumoral

Info

Publication number
BR0111202A
BR0111202A BR0111202-3A BR0111202A BR0111202A BR 0111202 A BR0111202 A BR 0111202A BR 0111202 A BR0111202 A BR 0111202A BR 0111202 A BR0111202 A BR 0111202A
Authority
BR
Brazil
Prior art keywords
compounds
necrosis factor
tumor necrosis
inhibitors
thienodibenzoazulene
Prior art date
Application number
BR0111202-3A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Dijana Pesic
Zeljko Zupanovic
Boska Hrvacic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of BR0111202A publication Critical patent/BR0111202A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"COMPOSTOS DE TIENODIBENZOAZULENO COMO INIBIDORES DO FATOR DE NECROSE TUMORAL". A presente invenção refere-se aos compostos de dibenzoazuleno representados pela fórmula I, bem como suas preparações farmacêuticas, para a inibição do fator a de necrose tumoral e interleucina 1 (IL-1) em mamíferos, em todas as doenças e condições nas quais estes mediadores são secretados excessivamente. Os compostos da presente invenção demonstram também uma ação analgética e podem ser usados para aliviar a dor.
BR0111202-3A 2000-05-17 2001-05-16 Compostos de tienodibenzoazuleno como inibidores do fator de necrose tumoral BR0111202A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000310A HRP20000310A2 (en) 2000-05-17 2000-05-17 New dibenzoazulene compounds as tumor necrosis factor inhibitors
PCT/HR2001/000027 WO2001087890A1 (en) 2000-05-17 2001-05-16 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors

Publications (1)

Publication Number Publication Date
BR0111202A true BR0111202A (pt) 2003-04-01

Family

ID=10947110

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111202-3A BR0111202A (pt) 2000-05-17 2001-05-16 Compostos de tienodibenzoazuleno como inibidores do fator de necrose tumoral

Country Status (37)

Country Link
US (2) US6897211B2 (pt)
EP (1) EP1284977B1 (pt)
JP (1) JP2003533528A (pt)
KR (1) KR100823064B1 (pt)
CN (1) CN1194976C (pt)
AR (1) AR030562A1 (pt)
AT (1) ATE434619T1 (pt)
AU (2) AU5656001A (pt)
BG (1) BG65967B1 (pt)
BR (1) BR0111202A (pt)
CA (1) CA2409090C (pt)
CR (1) CR6860A (pt)
CY (1) CY1109328T1 (pt)
CZ (1) CZ301770B6 (pt)
DE (1) DE60139070D1 (pt)
DK (1) DK1284977T3 (pt)
DZ (1) DZ3357A1 (pt)
EA (1) EA006069B1 (pt)
EE (1) EE200200636A (pt)
ES (1) ES2328335T3 (pt)
GE (1) GEP20043304B (pt)
HK (1) HK1056719A1 (pt)
HR (1) HRP20000310A2 (pt)
HU (1) HUP0302295A3 (pt)
IL (1) IL152809A0 (pt)
IS (1) IS6621A (pt)
MA (1) MA27125A1 (pt)
MX (1) MXPA02011269A (pt)
NO (1) NO20025510L (pt)
NZ (1) NZ522553A (pt)
PL (1) PL204849B1 (pt)
PT (1) PT1284977E (pt)
RS (1) RS50893B (pt)
SI (1) SI1284977T1 (pt)
SK (1) SK17702002A3 (pt)
WO (1) WO2001087890A1 (pt)
ZA (1) ZA200209180B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303B8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
EP1706394B1 (en) * 2003-11-12 2014-12-17 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
MX2007005073A (es) 2004-10-27 2007-06-25 Glaxosmithkline Zagreb Conjugados con actividad antiinflamtoria.
RU2401257C2 (ru) * 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
EP1844053A2 (en) * 2005-01-13 2007-10-17 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Anti-inflammatory macrolide conjugates
JP2009529057A (ja) 2006-03-08 2009-08-13 コートリア・コーポレーシヨン Ｃｏｘ−関連胃損傷を予防するための非−選択的ｃｏｘ阻害剤との組み合わせ療法
EP2114427B1 (en) 2007-01-30 2014-06-25 New York University Peptides for treatment of conditions associated with nitric oxide
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
JPS53116385A (en) * 1977-03-19 1978-10-11 Hokuriku Pharmaceutical Pyrazin derivative and method for its production
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
DE69720709T2 (de) * 1996-04-12 2004-03-11 Janssen Pharmaceutica N.V. Substituierte tetracyclische tetrahydrofuranderivate
GB9713368D0 (en) * 1997-06-25 1997-08-27 Weston Medical Ltd Flame control
EP0887339A1 (de) * 1997-06-27 1998-12-30 Roche Diagnostics GmbH Neue Azulenderivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
IS6621A (is) 2002-11-14
CA2409090C (en) 2010-06-29
EA200201223A1 (ru) 2003-06-26
CZ20024090A3 (cs) 2003-05-14
IL152809A0 (en) 2003-06-24
AU5656001A (en) 2001-11-26
BG65967B1 (bg) 2010-07-30
ES2328335T3 (es) 2009-11-12
AR030562A1 (es) 2003-08-27
HUP0302295A2 (hu) 2003-10-28
HRP20000310A2 (en) 2002-02-28
DE60139070D1 (de) 2009-08-06
CZ301770B6 (cs) 2010-06-16
JP2003533528A (ja) 2003-11-11
CR6860A (es) 2008-06-02
YU84102A (sh) 2006-01-16
SK17702002A3 (sk) 2003-10-07
CN1437605A (zh) 2003-08-20
NO20025510L (no) 2003-01-14
EE200200636A (et) 2004-04-15
NZ522553A (en) 2005-04-29
BG107399A (bg) 2003-09-30
KR100823064B1 (ko) 2008-04-18
PL365054A1 (en) 2004-12-27
GEP20043304B (en) 2004-02-10
EP1284977B1 (en) 2009-06-24
AU2001256560B2 (en) 2005-10-06
KR20030010625A (ko) 2003-02-05
WO2001087890A1 (en) 2001-11-22
HK1056719A1 (en) 2004-02-27
MXPA02011269A (es) 2003-06-06
PL204849B1 (pl) 2010-02-26
SI1284977T1 (sl) 2009-10-31
MA27125A1 (fr) 2005-01-03
RS50893B (sr) 2010-08-31
DK1284977T3 (da) 2009-09-14
US20030153750A1 (en) 2003-08-14
ATE434619T1 (de) 2009-07-15
CA2409090A1 (en) 2001-11-22
ZA200209180B (en) 2003-11-12
CY1109328T1 (el) 2012-05-23
DZ3357A1 (fr) 2001-11-22
PT1284977E (pt) 2009-09-09
EA006069B1 (ru) 2005-08-25
US20050171091A1 (en) 2005-08-04
US6897211B2 (en) 2005-05-24
CN1194976C (zh) 2005-03-30
HUP0302295A3 (en) 2007-03-28
EP1284977A1 (en) 2003-02-26
NO20025510D0 (no) 2002-11-15

Similar Documents

Publication Publication Date Title
BR0111202A (pt) Compostos de tienodibenzoazuleno como inibidores do fator de necrose tumoral
Moon et al. Aqueous extract of Codium fragile alleviates osteoarthritis through the MAPK/NF-κB pathways in IL-1β-induced rat primary chondrocytes and a rat osteoarthritis model
Chaudhary et al. Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study
Gokcen et al. A class of sulfonamides as carbonic anhydrase I and II inhibitors
BR0314071A (pt) Derivados de pró-droga de 1,3-diamino-2-hidroxipropano
BRPI0508561A (pt) 3-'4-heterociclil-1,2,3-triazol-1-il-n-aril-benzamidas como inibidores da produção de citocinas para o tratamento de doenças inflamatórias crÈnicas
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BR9807824A (pt) Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz
EA200400595A1 (ru) Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
BR0116380A (pt) Método e composições que empregam formulaçoes de óleos de lecitina e fármacos antiinflamatórios não-esteróides (nsaids) para proteger o trato gastrointestinal e proporcionar maior atividade terapêutica
GT199700085A (es) Inhibidores de metaloproteasas matriciales basados en fosfinatos
TR200102072T2 (tr) İltihap karşıtı maddeler olarak aromatik çok döngülü bileşimler
BRPI0408228A (pt) inibidores de citocinas
BRPI0409627A (pt) 2-hidróxi-3-diaminoalcanos de fenacila
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
Xu et al. Osthole improves collagen-induced arthritis in a rat model through inhibiting inflammation and cellular stress
WO1999009000A3 (en) Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
Dhaneshwar et al. Studies on synthesis, stability, release and pharmacodynamic profile of a novel diacerein-thymol prodrug
HK1094650A1 (en) The use of fumaric acid derivatives in the manufacture of a medicament for treating asthma and chronic obstructive pulmonary diseases
BRPI0509653A (pt) inibidores cinesina mitótica
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
WO2012041261A2 (es) Peptidos del veneno de escorpion rhopalorus junceus y composicion farmaceutica
AU7385398A (en) Novel macrocyclic compounds as metalloprotease inhibitors
Kim et al. DA-9601, Artemisia asiatica herbal extract, ameliorates airway inflammation of allergic asthma in mice
AR024907A1 (es) Uso de inhibidores de la produccion y/o accion de la il-18 y composiciones farmaceuticas formuladas con dichos inhibidores para el tratamiento demetastasis de tumores.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements